Skip to main content
Top
Published in: Journal of Translational Medicine 1/2008

Open Access 01-12-2008 | Review

Merger of Ayurveda and Tissue Culture-Based Functional Genomics: Inspirations from Systems Biology

Authors: Custer C Deocaris, Nashi Widodo, Renu Wadhwa, Sunil C Kaul

Published in: Journal of Translational Medicine | Issue 1/2008

Login to get access

Abstract

Ayurveda is one of the ancient systems of health care of Indian origin. Roughly translated into "Knowledge of life", it is based on the use of natural herbs and herb products for therapeutic measures to boost physical, mental, social and spiritual harmony and improve quality of life. Although sheltered with long history and high trust, ayurveda principles have not entered laboratories and only a handful of studies have identified pure components and molecular pathways for its life-enhancing effects. In the post-genomic era, genome-wide functional screenings for targets for diseases is the most recent and practical approach. We illustrate here the merger of ayurveda and functional genomics in a systems biology scenario that reveals the pathway analysis of crude and active components and inspire ayurveda practice for health benefits, disease prevention and therapeutics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wermuth CG: Multitargeted drugs: the end of the "one-target-one-disease" philosophy?. Drug Discov Today. 2004, 9: 826-827. 10.1016/S1359-6446(04)03213-1.CrossRefPubMed Wermuth CG: Multitargeted drugs: the end of the "one-target-one-disease" philosophy?. Drug Discov Today. 2004, 9: 826-827. 10.1016/S1359-6446(04)03213-1.CrossRefPubMed
2.
go back to reference Patwardhan B: Ethnopharmacology and drug discovery. J Ethnopharmacol. 2005, 100: 50-52. 10.1016/j.jep.2005.06.006.CrossRefPubMed Patwardhan B: Ethnopharmacology and drug discovery. J Ethnopharmacol. 2005, 100: 50-52. 10.1016/j.jep.2005.06.006.CrossRefPubMed
3.
go back to reference Patwardhan B, Warude D, Pushpangadan P, Bhatt N: Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med. 2005, 2: 465-473. 10.1093/ecam/neh140.PubMedCentralCrossRefPubMed Patwardhan B, Warude D, Pushpangadan P, Bhatt N: Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med. 2005, 2: 465-473. 10.1093/ecam/neh140.PubMedCentralCrossRefPubMed
4.
go back to reference Malik F, Singh J, Khajuria A, Suri KA, Satti NK, Singh S, Kaul MK, Kumar A, Bhatia A, Qazi GN: A standarized root extract of Whithania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci. 2007, 80: 1525-1538. 10.1016/j.lfs.2007.01.029.CrossRefPubMed Malik F, Singh J, Khajuria A, Suri KA, Satti NK, Singh S, Kaul MK, Kumar A, Bhatia A, Qazi GN: A standarized root extract of Whithania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci. 2007, 80: 1525-1538. 10.1016/j.lfs.2007.01.029.CrossRefPubMed
5.
go back to reference Hegde BM: Future Medicare system. J Assoc Physicians India. 2003, 51: 606-608.PubMed Hegde BM: Future Medicare system. J Assoc Physicians India. 2003, 51: 606-608.PubMed
6.
go back to reference Mishra LC, Singh BB, Dagenais S: Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev. 2000, 5: 334-346.PubMed Mishra LC, Singh BB, Dagenais S: Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev. 2000, 5: 334-346.PubMed
7.
go back to reference Winters M: Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev. 2006, 11: 269-277.PubMed Winters M: Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev. 2006, 11: 269-277.PubMed
8.
go back to reference Kulkarni SK, Dhir A: Withania somnifera: An Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2007, 2007, Sep 21, Kulkarni SK, Dhir A: Withania somnifera: An Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2007, 2007, Sep 21,
9.
go back to reference Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, Suri KA, Qazi GN, Singh J: Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis. 2007, 12: 2115-2133. 10.1007/s10495-007-0129-x.CrossRefPubMed Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, Suri KA, Qazi GN, Singh J: Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis. 2007, 12: 2115-2133. 10.1007/s10495-007-0129-x.CrossRefPubMed
10.
go back to reference Devi PU, Sharada AC, Solomon FE, Kamath MS: In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180. Indian J Exp Biol. 1992, 30: 169-172.PubMed Devi PU, Sharada AC, Solomon FE, Kamath MS: In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180. Indian J Exp Biol. 1992, 30: 169-172.PubMed
11.
go back to reference Devi PU, Sharada AC, Solomon FE: Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma-180. Indian J Exp Biol. 1993, 31: 607-611.PubMed Devi PU, Sharada AC, Solomon FE: Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma-180. Indian J Exp Biol. 1993, 31: 607-611.PubMed
12.
go back to reference Shohat B: Effect of withaferin A on cells in tissue culture. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1973, 80: 97-102. 10.1007/BF00305128.CrossRefPubMed Shohat B: Effect of withaferin A on cells in tissue culture. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1973, 80: 97-102. 10.1007/BF00305128.CrossRefPubMed
13.
go back to reference Shohat B, Gitter S, Abraham A, Lavie D: Antitumor activity of withaferin A (NSC-101088). Cancer Chemother Rep. 1967, 51: 271-276.PubMed Shohat B, Gitter S, Abraham A, Lavie D: Antitumor activity of withaferin A (NSC-101088). Cancer Chemother Rep. 1967, 51: 271-276.PubMed
14.
go back to reference Shohat B, Gitter S, Lavie D: Effect of withaferin A on Ehrlich ascites tumor cells–cytological observations. Int J Cancer. 1970, 5: 244-252. 10.1002/ijc.2910050212.CrossRefPubMed Shohat B, Gitter S, Lavie D: Effect of withaferin A on Ehrlich ascites tumor cells–cytological observations. Int J Cancer. 1970, 5: 244-252. 10.1002/ijc.2910050212.CrossRefPubMed
15.
go back to reference Shohat B, Joshua H: Effect of withaferin A on ehrlich ascites tumor cells. II. Target tumor cell destruction in vivo by immune activation. Int J Cancer. 1971, 8: 487-496.CrossRefPubMed Shohat B, Joshua H: Effect of withaferin A on ehrlich ascites tumor cells. II. Target tumor cell destruction in vivo by immune activation. Int J Cancer. 1971, 8: 487-496.CrossRefPubMed
16.
go back to reference Widodo N, Kaur K, Shrestha BG, Takagi Y, Ishii , Wadhwa R, Kaul SC: Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res. 2007, 13: 2298-2306. 10.1158/1078-0432.CCR-06-0948.CrossRefPubMed Widodo N, Kaur K, Shrestha BG, Takagi Y, Ishii , Wadhwa R, Kaul SC: Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res. 2007, 13: 2298-2306. 10.1158/1078-0432.CCR-06-0948.CrossRefPubMed
17.
go back to reference Widodo N, Takagi Y, Shrestha BG, Ishii T, Kaul SC, Wadhwa R: Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses. Cancer Lett. 2008, 2008, Jan 9 Widodo N, Takagi Y, Shrestha BG, Ishii T, Kaul SC, Wadhwa R: Selective killing of cancer cells by leaf extract of Ashwagandha: Components, activity and pathway analyses. Cancer Lett. 2008, 2008, Jan 9
18.
go back to reference Senthil V, Ramadevi S, Venkatakrishnan V, Giridharan P, Lakshmi BS, Vishwakarma RA, Balakrishnan A: Withanolide induces apoptosis in HL-60 leukemia cells via mitochondria mediated cytochrome c release and caspase activation. Chem Biol Interact. 2007, 167: 19-30. 10.1016/j.cbi.2007.01.004.CrossRefPubMed Senthil V, Ramadevi S, Venkatakrishnan V, Giridharan P, Lakshmi BS, Vishwakarma RA, Balakrishnan A: Withanolide induces apoptosis in HL-60 leukemia cells via mitochondria mediated cytochrome c release and caspase activation. Chem Biol Interact. 2007, 167: 19-30. 10.1016/j.cbi.2007.01.004.CrossRefPubMed
19.
go back to reference Singh DD, Dey CS, Bhutani KK: Downregulation of p34cdc2 expression with aqueous fraction from Withania somnifera for a possible molecular mechanism of anti-tumor and other pharmacological effects. Phytomedicine. 2001, 8: 492-494. 10.1078/S0944-7113(04)70072-0.CrossRefPubMed Singh DD, Dey CS, Bhutani KK: Downregulation of p34cdc2 expression with aqueous fraction from Withania somnifera for a possible molecular mechanism of anti-tumor and other pharmacological effects. Phytomedicine. 2001, 8: 492-494. 10.1078/S0944-7113(04)70072-0.CrossRefPubMed
20.
go back to reference Yang H, Shi G, Dou QP: The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry". Mol Pharmacol. 2007, 71: 426-437. 10.1124/mol.106.030015.CrossRefPubMed Yang H, Shi G, Dou QP: The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry". Mol Pharmacol. 2007, 71: 426-437. 10.1124/mol.106.030015.CrossRefPubMed
21.
go back to reference Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D: Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 2007, 67: 246-253. 10.1158/0008-5472.CAN-06-2430.CrossRefPubMed Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D: Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 2007, 67: 246-253. 10.1158/0008-5472.CAN-06-2430.CrossRefPubMed
22.
go back to reference Kaur K, Widodo N, Nagpal A, Kaul SC, Wadhwa R: Sensitization of human cancer cells to anti-cancer drugs by leaf extract of Ashwagandha (LASH). Tiss Cult Res Commun. 2007, 26: 171-183. Kaur K, Widodo N, Nagpal A, Kaul SC, Wadhwa R: Sensitization of human cancer cells to anti-cancer drugs by leaf extract of Ashwagandha (LASH). Tiss Cult Res Commun. 2007, 26: 171-183.
23.
go back to reference Kaileh M, Vanden Berghe W, Heyerick A, Horion J, Piette J, Libert C, De Keukeleire D, Essawi T, Haegeman G: Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem. 2007, 282: 4253-4264. 10.1074/jbc.M606728200.CrossRefPubMed Kaileh M, Vanden Berghe W, Heyerick A, Horion J, Piette J, Libert C, De Keukeleire D, Essawi T, Haegeman G: Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem. 2007, 282: 4253-4264. 10.1074/jbc.M606728200.CrossRefPubMed
24.
go back to reference Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG, Aggarwal BB: Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression. Cancer Ther. 2006, 5 (6): 1434-1445. 10.1158/1535-7163.MCT-06-0096.CrossRef Ichikawa H, Takada Y, Shishodia S, Jayaprakasam B, Nair MG, Aggarwal BB: Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression. Cancer Ther. 2006, 5 (6): 1434-1445. 10.1158/1535-7163.MCT-06-0096.CrossRef
25.
go back to reference Hudson J, Altamirano M: The application of DNA micro-arrays (gene arrays) to the study of herbal medicines. J Ethnopharmacol. 2006, 108: 2-15. 10.1016/j.jep.2006.08.013.CrossRefPubMed Hudson J, Altamirano M: The application of DNA micro-arrays (gene arrays) to the study of herbal medicines. J Ethnopharmacol. 2006, 108: 2-15. 10.1016/j.jep.2006.08.013.CrossRefPubMed
26.
go back to reference Fustier P, Le Corre L, Chalabi N, Vissac-Sabatier C, Communal Y, Bignon YJ, Bernard-Gallon DJ: Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines. Br J Cancer. 2003, 89: 168-172. 10.1038/sj.bjc.6600983.PubMedCentralCrossRefPubMed Fustier P, Le Corre L, Chalabi N, Vissac-Sabatier C, Communal Y, Bignon YJ, Bernard-Gallon DJ: Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines. Br J Cancer. 2003, 89: 168-172. 10.1038/sj.bjc.6600983.PubMedCentralCrossRefPubMed
27.
go back to reference Yang NS, Shyur LF, Chen CH, Wang SY, Tzeng CM: Medicinal herb extract and a single-compound drug confer similar complex pharmacogenomic activities in mcf-7 cells. J Biomed Sci. 2004, 11: 418-422. 10.1007/BF02254447.CrossRefPubMed Yang NS, Shyur LF, Chen CH, Wang SY, Tzeng CM: Medicinal herb extract and a single-compound drug confer similar complex pharmacogenomic activities in mcf-7 cells. J Biomed Sci. 2004, 11: 418-422. 10.1007/BF02254447.CrossRefPubMed
28.
go back to reference Wong ML, O'Kirwan F, Hannestad JP, Irizarry KJ, Elashoff D, Licinio J: St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatry. 2004, 9: 237-251. 10.1038/sj.mp.4001470.CrossRefPubMed Wong ML, O'Kirwan F, Hannestad JP, Irizarry KJ, Elashoff D, Licinio J: St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatry. 2004, 9: 237-251. 10.1038/sj.mp.4001470.CrossRefPubMed
29.
go back to reference Zhang S, Jin G, Zhang XS, Chen L: Discovering functions and revealing mechanisms at molecular level from biological networks. Proteomics. 2007, 7: 2856-2869. 10.1002/pmic.200700095.CrossRefPubMed Zhang S, Jin G, Zhang XS, Chen L: Discovering functions and revealing mechanisms at molecular level from biological networks. Proteomics. 2007, 7: 2856-2869. 10.1002/pmic.200700095.CrossRefPubMed
30.
go back to reference Kawamura A, Brekman A, Grigoryev Y, Hasson TH, Takaoka A, Wolfe S, Soll CE: Rediscovery of natural products using genomic tools. Bioorg Med Chem Lett. 2006, 16: 2846-2849. 10.1016/j.bmcl.2006.03.022.CrossRefPubMed Kawamura A, Brekman A, Grigoryev Y, Hasson TH, Takaoka A, Wolfe S, Soll CE: Rediscovery of natural products using genomic tools. Bioorg Med Chem Lett. 2006, 16: 2846-2849. 10.1016/j.bmcl.2006.03.022.CrossRefPubMed
Metadata
Title
Merger of Ayurveda and Tissue Culture-Based Functional Genomics: Inspirations from Systems Biology
Authors
Custer C Deocaris
Nashi Widodo
Renu Wadhwa
Sunil C Kaul
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2008
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-6-14

Other articles of this Issue 1/2008

Journal of Translational Medicine 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.